SUSAN BOBULSKY - 25 Jan 2024 Form 3 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Chief Commercial Officer, MRD
Signature
/s/ Susan Bobulsky by Stacy L. Taylor, Attorney-in-Fact
Issuer symbol
ADPT
Transactions as of
25 Jan 2024
Net transactions value
$0
Form type
3
Filing time
06 Mar 2024, 19:38:34 UTC
Next filing
06 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ADPT Common Stock 128,302 25 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADPT Stock Option (Right to Buy) 25 Jan 2024 Common Stock 5,000 $1.98 Direct F1
holding ADPT Stock Option (Right to Buy) 25 Jan 2024 Common Stock 20,000 $6.27 Direct F1
holding ADPT Stock Option (Right to Buy) 25 Jan 2024 Common Stock 28,750 $6.55 Direct F1
holding ADPT Stock Option (Right to Buy) 25 Jan 2024 Common Stock 13,474 $28.32 Direct F2
holding ADPT Stock Option (Right to Buy) 25 Jan 2024 Common Stock 20,000 $39.50 Direct F3
holding ADPT Stock Option (Right to Buy) 25 Jan 2024 Common Stock 22,894 $43.68 Direct F4
holding ADPT Stock Option (Right to Buy) 25 Jan 2024 Common Stock 102,965 $12.14 Direct F5
holding ADPT Stock Option (Right to Buy) 25 Jan 2024 Common Stock 88,689 $8.46 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are fully exercisable.
F2 The options will vest with respect to 1/4 of such shares on February 27, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3 The options will vest with respect to 1/4 of such shares on August 6, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F4 The options will vest with respect to 1/4 of such shares on March 4, 2022, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F5 The options will vest with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F6 The options will vest with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.